Atlas FDA

HardyCHROM MRSA,REF; G307, LOT: 447694, A selective and differential chromogenic medium for the qualitative direct detec

FDA device recall Z-2298-2020 · posted 2020-06-09 · Terminated

Recall details

Recalling firm
Hardy Diagnostics
Reason for recall
False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.
Action taken
On 11/14/2019, the firm sent a notification of recall letter to customers, informing them of the performance issue of the device lot of the breakthrough on firm's differential chromogenic medium. The customers were advised to discard the remaining stock, and notify the Technical Services Department. If the customer would like replacement or credit, contact Technical Services Department or via e-mail at TechService@HardyDiagnostics.com, or 800-266-2222 option 2 or ext. 5658.
Root cause
Nonconforming Material/Component
Status
Terminated
Product code
JSO
Quantity affected
3,580 ea (358 kits, pack of 10 in each)
Distribution
U.S. Distribution in the states of WI, CA, WA, IA, MT, UT, AZ, WY, KS, MO, OR, TX, VI, including PR and Guam. OUS: British Virgin Islands, Kenya,
Date initiated
2019-11-14
Date posted
2020-06-09
Date terminated
2021-04-28
Location
Santa Maria, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
HARDYCHROM MRSA (K102922)Hardy Diagnostics2011-05-04